Verona Pharma PLC (VRNA)
12.07
+0.59
(+5.14%)
USD |
NASDAQ |
May 31, 16:00
12.09
+0.02
(+0.17%)
After-Hours: 20:00
Verona Pharma Shares Outstanding: 81.08M for May 2, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 02, 2024 | 81.08M |
March 31, 2024 | 80.92M |
March 13, 2024 | 77.45M |
February 23, 2024 | 80.82M |
December 31, 2023 | 80.44M |
October 27, 2023 | 79.94M |
September 30, 2023 | 79.94M |
July 27, 2023 | 79.48M |
June 30, 2023 | 79.47M |
May 02, 2023 | 79.46M |
March 31, 2023 | 79.00M |
March 03, 2023 | 78.99M |
December 31, 2022 | 75.79M |
November 03, 2022 | 75.62M |
September 30, 2022 | 75.28M |
August 03, 2022 | 60.95M |
June 30, 2022 | 60.66M |
March 01, 2022 | 60.37M |
December 31, 2021 | 60.01M |
November 08, 2021 | 60.01M |
September 30, 2021 | 59.71M |
August 04, 2021 | 60.04M |
June 30, 2021 | 58.98M |
April 27, 2021 | 57.97M |
March 31, 2021 | 57.97M |
Date | Value |
---|---|
March 12, 2021 | 57.91M |
March 01, 2021 | 57.91M |
February 19, 2021 | 57.93M |
December 31, 2020 | 57.91M |
November 09, 2020 | 57.90M |
August 25, 2020 | 57.80M |
July 31, 2020 | 57.80M |
July 22, 2020 | 57.80M |
June 30, 2020 | 13.31M |
December 31, 2019 | 13.17M |
December 31, 2018 | 13.17M |
April 30, 2018 | 13.13M |
February 01, 2018 | 13.13M |
December 31, 2017 | 13.13M |
September 30, 2017 | 13.13M |
September 22, 2017 | 13.13M |
June 30, 2017 | 13.11M |
May 30, 2017 | 13.11M |
May 26, 2017 | 13.11M |
May 19, 2017 | 13.07M |
May 18, 2017 | 13.07M |
May 03, 2017 | 12.38M |
May 02, 2017 | 12.38M |
February 13, 2017 | 6.420M |
January 06, 2017 | 6.420M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
13.17M
Minimum
Dec 31 2019
81.08M
Maximum
May 02 2024
64.85M
Average
60.37M
Median
Mar 01 2022
Shares Outstanding Benchmarks
Biodexa Pharmaceuticals Plc | 9.632M |
NuCana PLC | 2.266M |
Bicycle Therapeutics PLC | 68.73M |
TC BioPharm (Holdings) PLC | 4.945M |
Adaptimmune Therapeutics PLC | 255.56M |